Animal work
Therefore, potent, short-acting DPP-IV inhibitors taken at meal time might provide brief stimulation of insulin secretion by increasing levels of insulinotropic GLP-1 (7-36) amide, allowing escape from DPP-IV inhibition and the intermittent production of insulinomimetic GLP-1 (9-36) amide during interprandial periods
These are mostly harmless, but injecting a large amount of air is painful and even fatal in large doses
As we move forward, continued research, careful monitoring, and collaborative efforts between healthcare providers, researchers, policymakers, and families will be essential to optimize the use of these medications and improve outcomes for adolescents with obesity
Frequency and Timing of Dizziness on Tirzepatide Clinical trials of tirzepatide report dizziness in roughly 58% of participants across all dose levels, with most incidents occurring in the first two to four weeks of treatment